Andersen, I. B. Et Al. 2022. Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis. CLINICAL ENDOCRINOLOGY , vol.97, no.5 , 519-531.

Andersen, I. B., Sorensen, M. G. R., Dogansen, S. C., Ku, C. R., Vilar, L., Feldt-Rasmussen, U., ... Krogh, J.(2022). Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis. CLINICAL ENDOCRINOLOGY , vol.97, no.5, 519-531.

Andersen, Ida Et Al. "Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis," CLINICAL ENDOCRINOLOGY , vol.97, no.5, 519-531, 2022

Andersen, Ida B. Et Al. "Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis." CLINICAL ENDOCRINOLOGY , vol.97, no.5, pp.519-531, 2022

Andersen, I. B. Et Al. (2022) . "Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis." CLINICAL ENDOCRINOLOGY , vol.97, no.5, pp.519-531.

@article{article, author={Ida B. Andersen Et Al. }, title={Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis}, journal={CLINICAL ENDOCRINOLOGY}, year=2022, pages={519-531} }